EXC

EXC Shares In Range of 52 Week High

This morning we watched Exelon rise 1.1% to a price of $40.67 per share. The large-cap Utilities—Independent Power Producers company is now trading -9.95% below its average target price of $45.17. Analysts have set target prices ranging from $39.0 to $48.0 per share for Exelon, and have given the stock an average rating of buy.

Exelon's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.6%. The stock's short ratio is 2.65. The company's insiders own 0.21% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 85.2%. In conclusion, we believe there is mixed market sentiment regarding Exelon.

Institutions Invested in Exelon

Date Reported Holder Percentage Shares Value
2023-06-30 Wellington Management Group, LLP 9% 90,844,170 $3,695,086,545
2023-06-30 Vanguard Group Inc 9% 90,335,712 $3,674,405,016
2023-06-30 Blackrock Inc. 9% 86,731,996 $3,527,823,871
2023-06-30 State Street Corporation 6% 62,856,389 $2,556,683,574
2023-06-30 Bank Of New York Mellon Corporation 2% 21,390,309 $870,050,802
2023-06-30 T. Rowe Price Investment Management, Inc. 2% 21,211,931 $862,795,277
2023-06-30 Deutsche Bank Aktiengesellschaft 2% 20,024,542 $814,498,230
2023-06-30 Massachusetts Financial Services Co. 2% 19,849,920 $807,395,480
2023-06-30 Geode Capital Management, LLC 2% 18,931,213 $770,027,074
2023-06-30 Morgan Stanley 2% 17,487,413 $711,300,510
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS